Raymond James lowered shares of UnitedHealth Group (NYSE:UNH – Get Rating) from a strong-buy rating to an outperform rating in a research note published on Monday morning, The Fly reports. They currently have $615.00 price objective on the healthcare conglomerate’s stock.
A number of other brokerages have also recently weighed in on UNH. Argus boosted their price target on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a buy rating in a research report on Monday, July 25th. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $588.00 to $592.00 and gave the company an outperform rating in a report on Monday, October 17th. SVB Leerink dropped their price target on shares of UnitedHealth Group from $625.00 to $618.00 and set an outperform rating on the stock in a research note on Monday, October 17th. Credit Suisse Group boosted their price target on shares of UnitedHealth Group from $579.00 to $590.00 and gave the stock an outperform rating in a research note on Monday, October 17th. Finally, Mizuho boosted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a buy rating in a research note on Wednesday, August 10th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and an average target price of $595.11.
UnitedHealth Group Price Performance
UnitedHealth Group stock opened at $517.19 on Monday. The stock has a market cap of $483.24 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 1.65 and a beta of 0.75. The company has a fifty day simple moving average of $523.47 and a 200-day simple moving average of $515.44. UnitedHealth Group has a 12-month low of $436.00 and a 12-month high of $558.10. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.58.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th will be issued a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Friday, December 2nd. UnitedHealth Group’s dividend payout ratio (DPR) is presently 32.32%.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.40% of the company’s stock.
Hedge Funds Weigh In On UnitedHealth Group
Institutional investors and hedge funds have recently modified their holdings of the company. TimeScale Financial Inc. lifted its stake in shares of UnitedHealth Group by 276.9% during the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after buying an additional 36 shares during the period. Pflug Koory LLC raised its stake in UnitedHealth Group by 160.0% during the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 32 shares during the period. Urban Wealth Management LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $29,000. Knott David M Jr purchased a new position in UnitedHealth Group during the second quarter worth approximately $29,000. Finally, Rothschild & Co Wealth Management UK Ltd purchased a new position in UnitedHealth Group during the second quarter worth approximately $31,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Ardelyx is A Buy After Slip in Early 2022
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.